Scarsdale, NY, United States of America

Chiayang Lin


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Chiayang Lin: Pioneering Antigen Binding Molecules

Introduction

Chiayang Lin, an inventive mind based in Scarsdale, NY, has made significant contributions to the field of molecular biology and cancer treatment through his innovative work on antigen binding molecules. With one patent to his name, Lin is recognized for his commitment to developing strategies for combating cancer, pivotal in today’s research landscape.

Latest Patents

Chiayang Lin's notable patent focuses on "Antigen binding molecule formats." This invention encompasses antigen binding molecules (ABMs) featuring Fab domains in non-native configurations. The patent details ABM conjugates that integrate cytotoxic or cytostatic agents, as well as pharmaceutical compositions containing these ABMs and conjugates. Additionally, it outlines methods for using these molecules in cancer treatment, nucleic acids encoding the ABMs, and specially engineered cells that express the ABMs, further expanding the potential applications in biomedical science.

Career Highlights

Lin's professional journey is marked by his role at Regeneron Pharmaceuticals, Inc., a leader in biotechnology. His work there underscores a deep commitment to not only advancing scientific understanding but also translating innovations into tangible therapies that can save lives. His dedication has carved a niche in the competitive field of pharmaceutical research.

Collaborations

Throughout his career, Chiayang Lin has collaborated with peers, including notable coworker Erica Pyles. This collaboration is indicative of the dynamic teamwork required in large-scale research endeavors. Together, they strive to advance the development of novel therapeutic solutions that can impact patient care positively.

Conclusion

Chiayang Lin's contributions to the field of antigen binding molecules reflect a blend of creativity and scientific rigor. His patent, alongside his work at Regeneron Pharmaceuticals, has the potential to influence future cancer treatment methodologies. As the landscape of healthcare continues to evolve, innovations like Lin's will play a critical role in addressing some of the most challenging health issues of our time.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…